These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14528086

  • 1. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
    Yamazaki Y, Chiba I, Hirai A, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Iizuka T, Kohgo T, Fukuda H.
    Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
    [Abstract] [Full Text] [Related]

  • 2. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T.
    Oncogene; 1997 Nov 27; 15(22):2667-74. PubMed ID: 9400993
    [Abstract] [Full Text] [Related]

  • 3. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea.
    Thomas S, Brennan J, Martel G, Frazer I, Montesano R, Sidransky D, Hollstein M.
    Cancer Res; 1994 Jul 01; 54(13):3588-93. PubMed ID: 8012986
    [Abstract] [Full Text] [Related]

  • 4. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN.
    Clin Cancer Res; 2003 Jan 01; 9(1):228-34. PubMed ID: 12538474
    [Abstract] [Full Text] [Related]

  • 5. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
    Chaves AC, Cherubini K, Herter N, Furian R, Santos DS, Squier C, Domann FE.
    Int J Oncol; 2004 Feb 01; 24(2):295-303. PubMed ID: 14719105
    [Abstract] [Full Text] [Related]

  • 6. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Sanghavi V, Mehta AR.
    Oral Oncol; 1999 May 01; 35(3):242-50. PubMed ID: 10621843
    [Abstract] [Full Text] [Related]

  • 7. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Têtu B.
    Int J Oral Maxillofac Surg; 2000 Feb 01; 29(1):36-41. PubMed ID: 10691142
    [Abstract] [Full Text] [Related]

  • 8. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
    Chen Q, Fu J, Yang G.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov 01; 31(6):337-40. PubMed ID: 9592286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [p53 alterations and HPV status in oral squamous cell carcinomas].
    Barten M, Ostwald C, Müller P, Löning T, Milde-Langosch K, Wukasch Y.
    Verh Dtsch Ges Pathol; 1994 Nov 01; 78():255-9. PubMed ID: 7533995
    [Abstract] [Full Text] [Related]

  • 11. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R, Jović N, Magić Z, Branković-Magić M, Minić V.
    J Craniomaxillofac Surg; 2005 Oct 01; 33(5):342-8. PubMed ID: 16129609
    [Abstract] [Full Text] [Related]

  • 12. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
    Shahnavaz SA, Regezi JA, Bradley G, Dubé ID, Jordan RC.
    J Pathol; 2000 Mar 01; 190(4):417-22. PubMed ID: 10699989
    [Abstract] [Full Text] [Related]

  • 13. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M, Nakatsuka T, Kusama K, Sakashita H.
    J Oral Maxillofac Surg; 2006 Nov 01; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.
    Sakai E, Tsuchida N.
    Oncogene; 1992 May 01; 7(5):927-33. PubMed ID: 1570156
    [Abstract] [Full Text] [Related]

  • 17. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.
    Bhawal UK, Tsukinoki K, Sasahira T, Sato F, Mori Y, Muto N, Sugiyama M, Kuniyasu H.
    Oncol Rep; 2007 Oct 01; 18(4):817-24. PubMed ID: 17786341
    [Abstract] [Full Text] [Related]

  • 18. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1322-31. PubMed ID: 12433709
    [Abstract] [Full Text] [Related]

  • 19. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X, Fu Y, Liu S, Liang C.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr 01; 36(2):142-5. PubMed ID: 12761985
    [Abstract] [Full Text] [Related]

  • 20. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T, Zhang ZF.
    Cancer; 2004 Aug 15; 101(4):834-44. PubMed ID: 15305417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.